FDA Advisory Committee Recommends Approval Of Multaq (dronedarone) (Medical News Today)
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that the Cardiovascular and Renal Drugs Advisory Committee voted 10 to 3 in favor of the approval of Multaq by the U.S. Food and Drug Administration (FDA) to treat patients with non-permanent atrial fibrillation (AF).

FDA Approves Two News HPV Tests For Women Age 30 And Older (Medical News Today)
FDA has approved two new tests, developed by Bedford, Mass.-based Hologic, to screen for high-risk human papillomavirus types, the Boston Herald reports. Currently, there is only one FDA-approved test for HPV on the market, the Herald reports. Certain strains of HPV are a precursor to cervical cancer (McConville, Boston Herald, 3/14). According to U.S.

Strides receives US FDA inspection approval status for steriles injectable complex (PharmaBiz)
Strides Arcolab has bagged a US FDA inspection approval status for its Bangalore facility after a GMP and pre-approval inspection at its sterile complex which was audited for cGMP compliance.